Shield Therapeutics shares drop 30% after raising $10 million loan
- Raises $10 million via shareholder loan agreement- More funding needed to achieve US roll-out- Good progress on commercializing AccuferIron deficiency-focused pharma company Shield Therapeutics (STX:AIM) said it will raise $10...
30 June 2022